Candida parapsilosis, Candida tropicalis, and so on. 2 However, the etiology of high VVC recurrence is non-albicans Candida species and the prevalence of other Candida species including C. glabrata is increasing in recent years. 3 Moreover, up to 6% women will suffer from recurrent VVC (RVVC), 4 which consists in acute and symptomatic individuals. 5 Candida species is generally in yeast phase under the normal circumstances. In some cases, phenotypic switching will occur in C. albicans, which is from yeast phase to hypha phase. [6] [7] [8] The phenotypic switching may lead to antigenic changes on the cell membrane, local immune response in mucosa, and the occurrence of vaginal inflammation and susceptibility to different antifungal drugs. 9 This study was designed to investigate the changes of antifungal susceptibility testing caused by the phenotypic switching in patients with VVC, which was benefit for rational use of antifungal drugs.
| MATERIAL S AND ME THODS

| Samples collection
In this study, 229 patients were enrolled from the obstetrics 
| Gram staining and microscopic observation
| Fungal culture
The vaginal discharge in cotton wool-tipped swabs was cultured in sabouraud's agar with chloramphenicol medium (Jinzhang science and technology development limited company, Tianjin). After incubation at 37°C for 2-3 days, the gray-white cheese colonies formed.
Ovoid yeasts and pseudohyphae were also observed after gram staining. The colony would be regarded as C. albicans or non-albicans Candida species.
| Fungal identification and in vitro antifungal susceptibility testing
After fungal culture, fungal identification was analyzed using CHROM agar Candida chromogenic and identification medium (CHROM agar ≥32 mg/L, resistant. The susceptibilities of isolates to amphotericin B were assayed as described previously. 16 The minimum inhibitory concentration (MIC) for amphotericin B was defined as the lowest drug concentration at which growth was completely inhibited. 17 
| Statistical analysis
The data analysis was performed by SPSS Statistics ver. 17.0 (SPSS Inc., Chicago, IL, USA). The comparison of different prevalence among Candida species and the different positive rates of phenotypic switching were analyzed by Chi-squared test. A 2-tailed P < 0.05 was considered statistically significant and a 2-tailed P < 0.01 was considered extremely statistically significant.
| RE SULTS
| Results of microscopic observation and fungal identification
In CHROM agar Candida chromogenic and identification mediums, the colonies were shown in Figures 1 and 2 . The colony color of C. albicans was green (diameter: 2 mm), while the colony color of C. glabrata was purple (diameter: 2 mm). The colony color of C. krusei and C. tropicalis was soft pink (diameter: 4-5 mm) and blue gray or iron blue (diameter:
1.5 mm) respectively. The colony color of C. parapsilosis was white.
According to the colony morphology, 64.63% of Candia species in patients with VVC were identified as C. Albicans(n = 148) and the remainders (n = 81, 35.37%) were identified as non-albicans Candida species (showed in 
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Based on related literature by Ilkit et al, 11 after gram staining, the finding of pseudohyphae was regarded as phenotypic switching ( Figure 3A) . And the finding of yeasts without budding (without pseudohyphae) was regarded as non-phenotypic switching ( Figure 3B ). The yeasts with budding and pseudohyphae were observed in 91.22% of clinical isolates identified as C. albicans, which indicated that 91.22% of these clinical isolates were with phenotypic switching. The remainder (8.78%) was without phenotypic switching.
Meanwhile, the pseudohypha was not observed in 80.25% of clinical isolates identified as non-albicans Candida species, which indicated that 80.25% of these clinical isolates was without phenotypic switching, the remainders (19.75%) was with phenotypic switching (showed in Table 1 ).
| Results of in vitro antifungal susceptibility testing
In antifungal susceptibility testing in vitro, the susceptible rates 
F I G U R E 1 The colors of Candida species in CHROMagar
Candida chromogenic and identification medium. The color of green and purple represents C. albicans and C. glabrata, respectively; the color of soft pink and blue-gray represents C. krusei and C. tropicalis, respectively
F I G U R E 2 The colors of two Candida species in CHROMagar
Candida chromogenic and identification medium. The color of iron blue and white represents the C. tropicalis and C. parapsilosis, respectively
| D ISCUSS I ON
In this study, through fungal morphology observation and fungal identification, C. albicans was found to be the main pathogen of VVC. This is consistent with the findings in previous studies.
20 -22 C. glabrata was the commonest pathogenic species in non-albicans Candida species is the main symbol of phenotypic switching. 11, 21 The hyphae can grow along the fissure of skin and mucosa by mechanical force and finally pass through the skin or skin epithelial cells, which are two important steps of fungal infection. 25 In antifungal susceptibility testing, the susceptible rates of C. albicans to all antifungal drugs were higher than non-albicans Candida species (Tab. 1). The susceptible rates of C. albicans to voriconazole, fluconazole and itraconazole were significantly higher than that of non-albicans Candida species, which indicated that the commonly used antifungal drugs aimed to VVC caused by C. albicans were more effective than that caused by non-albicans Candida species. Patients infected with non-albicans Candida species have various degrees of resistance to different antifungal drugs. 11 Azole antifungals are efficient in clearing the acute infection but unable to prevent the recurrence of VVC. So, it should be careful when using these two kinds of drugs. In summary, C. albicans was the commonest pathogenic species of VVC, which was easy to convert from yeast phase to hypha phase. Meanwhile, the phenotypic switching was rarely occurred in non-albicans Candida species. The susceptible rate of C. albicans to antifungal drugs was higher than that of non-albicans Candida species. No matters for patients infected with C. albicans or with non-albicans Candida species, the susceptible rates to fluconazole with phenotypic switching was significantly higher than that without phenotypic switching. So, the rational use of fluconazole would be based on the fungal phenotypic switching in patients with VVC.
Our study has some limitations. First, the sorts of antifungal drugs for susceptibility testing were quite less, which could not completely represent all antifungal drugs. Therefore, newer antifungal drugs will be used in our future studies. Second, in patients who infected with non-albicans Candida species, regardless of cases with or without phenotypic switching, the study number was relatively small, which may lead to statistical error to an extent. More cases will be enrolled in our future study. Third, although the antifungal susceptibilities of different non-albicans Candida species such as C. glabrata and C. parapsilosis are different, however, because of the small number and proportion of C. krusei, C. tropicalis, C. parapsilosis, and Saccharomyces cerevisiae cases, the susceptibilities of all non-albicans Candida isolates had to be counted together in our study.
Furthermore, molecular method such as PCR-RFLP analysis would be used to identify the Candida species instead of using CHROM agar Candida chromogenic and identification mediums.
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